Genus

(GNS)
Sector: Pharmaceuticals & Biotechnology
1,860.00p
-60.00p -3.13
Last updated: 16:57:19

Share information

Name Genus
Epic GNS
Isin GB0002074580
Index UK250 UK350
Industry Pharmaceuticals & Biotechnology

Key numbers

Latest share price 1,860.00p Net gearing n/a
Market capitalisation £1,228.25 Debt ratio n/a
Shares in issue 66.03 Debt-to-equity ratio n/a
P/E ratio 25.5 Assets / equity ratio n/a
Total dividends per share 10.30p Price to book value n/a
Dividend yield 1.5 ROCE 7.93
Dividend cover 2.65 EPS growth 2
Earning per share 50.8 52-week high / low 1,630.00p / 2,354.00p

Dividends

Type Ex-date Pay-date Net-dividend
Interim 2024-02-29 2024-03-28 10.30p
Final 2023-11-09 2023-12-08 21.70p
Interim 2023-03-02 2023-03-30 10.30p
Final 2022-11-17 2022-12-09 21.70p
Interim 2022-03-03 2022-03-31 10.30p
Final 2021-11-18 2021-12-10 21.70p
Interim 2021-03-04 2021-04-01 10.30p
Final 2020-11-19 2020-12-11 19.70p
Interim 2020-03-05 2020-04-02 9.40p

Contact details

Company name Genus
Address Matrix House, Basing View, Basingstoke, Hampshire, United Kingdom, RG21 4DZ
Telephone +44 (0) 1256 347 100
Website http://www.genusplc.com

Directors

Director Position
Mr Jorgen Kokke CEO
Mr Alison Henriksen CFO
Dr Ralph Heuser Non-Executive Director
Mr Iain Ferguson Non-Executive Chairman
Mrs Lesley Knox Senior Independent Director
Professor Jason Chin Independent Non-Executive Director
Ms Lysanne Gray Independent Non-Executive Director
Mr Dan Hartley General Counsel and Company Secretary

Company financials

Assets £ (m) 2023 2022 2021
Reporting date 30/06/23 30/06/22 30/06/21
Intangible asssets and goodwill 174 183 157.8
Investments and other non-current assets 53.5 41.2 48.8
Total non-current assets 748.5 760.4 619.3
Inventory / work in progress 61.3 50.9 37
Trade and other receivables 136.1 133.5 108.8
Cash and equivalents 36.3 38.8 46
Other current assets and asset held for resale 25.3 34.3 39.9
Total of all assets 1007.5 1017.9 851
Liabilities £ (m) 2023 2022 2021
Short term liabilities 147.2 151.3 142.5
Long term liabilities 293.1 294.5 211.9
Other liabilites / pension etc n/a n/a n/a
Total of all liabilities 440.3 445.8 354.4
Net assets £ (m) 2023 2022 2021
Net assets 567.2 572.1 496.6
Equity £ (m) 2023 2022 2021
Share capital 6.6 6.6 6.6
Minority interests -7.7 -6.4 -1.5
Retained earnings 360.6 340.6 320.4
Share premium account 179.1 179.1 179.1
Total equity 567.2 572.1 496.6
Income £ (m) 2023 2022 2021
Turnover n/a n/a n/a
Operating profit 40.5 49.4 47.7
Pre-tax profit 39.4 48.4 55.8